PDS Biotechnology Corp (PDSB)

[Fress]

out of Brazil-

The results of clinical studies (toxicity and immunogenicity) obtained so far demonstrate quality and competitiveness to be a national and global success in controlling COVID-19. The vaccine has demonstrated the ability to activate the entire immune system - humoral, cellular and innate immunity, induce immune memory and long-term protection.

Development of PDS0203 - A second generation COVID-19 vaccine that
promotes powerful T-cell responses and neutralizing antibodies.

Mt. Sinai data shows Versamune® promotes
induction of neutralizing antibodies with
lowest doses of SARS-CoV-2 antigen1

PDS generated data shows induction of
SARS-CoV-2 specific CD8+ T-cells with
Versamune®2


PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine
PDS0203 prioritized for clinical development by PDS Biotech and Farmacore after successful meeting with Brazilian Drug Regulatory Agency.

As previously disclosed, PDS Biotech has generated robust preclinical data demonstrating that PDS0203 elicits a 30-45 fold increase in the induction of highly active and potent virus-specific T-cells within 14 days of treatment compared to the vaccine without Versamune®. Importantly, the study also demonstrated induction of the long-lasting virus-specific memory T-cells necessary for longer term protection. The vaccine has also demonstrated strong and long-lasting induction of neutralizing antibodies. The PDS0203 subunit vaccine is based on recombinant proteins and does not require the use of inactivated viruses, traditional adjuvants, DNA or RNA to induce robust protective immune responses.

We will have a second generation CV-19 vaccine in Brazil by the end of the year.

The second generation Covid-19 Universal flu vaccine is the icing on the cake.

PDSB next level cutting edge oncology pipeline three phase 2 studies ongoing with world renown cancer institutes & MERCK. Very possible this company will be bought out in the next year or so. 47 an immunotherapy company was bought by Gilead for 4.6 billion dollars in phase 1 studies.


PDSB 0203 Vaccine can protect against all CV-19 strains!!

Normalcy only when second generation of Covid-19 vaccine is out’: Bill Gates.

PDSB website:
https://www.pdsbiotech.com/

PDSB 2021 biz presentation:
https://www.pdsbiotech.com/images/pdf/presentation/2021/PDSB_Corporate_Overview_-_Jan_2021_FINAL-1.pdf





$PDSB